|
Market Closed -
Japan Exchange
09:30:00 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2,448.50 JPY | -1.67% |
|
-0.35% | +12.70% |
| 09-02 | Ono Pharmaceutical Co., Ltd. Enters Into Drug Discovery Partnership With Aitia, Inc | CI |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| Market Cap | 1,151B 7.37B 6.34B 5.97B 5.45B 10.2B 696B 10.23B 70.53B 27.37B 357B 27.69B 27.08B | P/E 2027 * |
15.8x | P/E 2028 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 949B 6.08B 5.24B 4.93B 4.5B 8.42B 574B 8.44B 58.21B 22.59B 295B 22.85B 22.35B | EV / Sales 2027 * |
2.07x | EV / Sales 2028 * | 2.01x |
| Free-Float |
81.92% | Yield 2027 * |
3.19% | Yield 2028 * | 3.16% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4528 | Delayed | |
OTC Markets
| OPHLF | Delayed | |
|
Börse Stuttgart
| ON4 | Delayed | |
|
Boerse Muenchen
| ON4 | Real-time | |
|
Deutsche Boerse AG
| ON4 | Delayed | |
|
Tradegate
| ON4 | Real-time |
Last Transcript : Ono Pharmaceutical Co., Ltd.
| 1 day | -1.67% | ||
| 1 week | -0.35% | ||
| Current month | -0.08% | ||
| 1 month | +6.41% | ||
| 3 months | +10.04% | ||
| 6 months | -1.78% | ||
| Current year | +12.70% |
| 1 week | 2,419.5 |  | 2,511 |
| 1 month | 2,332.5 | | 2,517.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,674 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 01/04/2024 |
Masaki Ito
DFI | Director of Finance/CFO | - | 01/04/2026 |
Toichi Takino
PSD | President | 57 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 01/04/2024 |
Toichi Takino
BRD | Director/Board Member | 57 | 01/06/2020 |
Masao Nomura
BRD | Director/Board Member | 77 | 26/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.67% | -0.35% | +41.04% | -11.59% | 7.37B | |
| -0.89% | -1.09% | +19.16% | +67.77% | 48.26B | |
| -1.72% | -1.15% | +45.80% | +117.34% | 40.5B | |
| -0.70% | -2.70% | -10.84% | +11.79% | 11.85B | |
| -2.01% | -5.96% | +10.47% | +76.64% | 11.83B | |
| +2.31% | 0.00% | +26.67% | +153.33% | 9.36B | |
| +0.08% | -4.11% | +24.83% | +43.80% | 7.5B | |
| -0.89% | -3.09% | +18.78% | +207.82% | 7.28B | |
| -0.16% | -2.36% | -46.14% | +16.28% | 5.19B | |
| -1.60% | -2.59% | +32.54% | +102.62% | 4.58B | |
| Average | -0.72% | -2.14% | +16.23% | +78.58% | 15.37B | |
| Weighted average by Cap. | -0.97% | -1.74% | +23.16% | +83.37% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 458B 2.94B 2.53B 2.38B 2.17B 4.06B 277B 4.08B 28.11B 10.91B 142B 11.03B 10.79B | 448B 2.87B 2.47B 2.33B 2.13B 3.98B 271B 3.99B 27.49B 10.67B 139B 10.79B 10.56B |
| Net income | 72.89B 467M 402M 378M 345M 646M 44.1B 648M 4.47B 1.73B 22.63B 1.75B 1.72B | 63.15B 405M 348M 328M 299M 560M 38.21B 561M 3.87B 1.5B 19.6B 1.52B 1.49B |
| Net Debt | -201B -1.29B -1.11B -1.04B -953M -1.78B -122B -1.79B -12.33B -4.78B -62.42B -4.84B -4.73B | -250B -1.6B -1.38B -1.3B -1.18B -2.21B -151B -2.22B -15.31B -5.94B -77.51B -6.01B -5.88B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | ¥2,448.50 | -1.67% | 1,559,800 |
| 03/09/26 | ¥2,490.00 | +0.81% | 1,481,700 |
| 02/09/26 | ¥2,470.00 | -0.62% | 1,460,800 |
| 01/09/26 | ¥2,485.50 | +1.43% | 1,029,200 |
| 31/08/26 | ¥2,450.50 | -0.26% | 1,569,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
